@misc{indiciaebd7530a94477,
  title = {Efficacy and safety of once-weekly semaglutide 2\&\#xb7;4 mg in Chinese adults with overweight or obesity (STEP 12): a randomised, double-blind, placebo-controlled, multicentre, phase 3b trial.},
  author = {Lixin Guo and Xiaolei Bao and Kuo-Chin Huang and Kristoffer Jensen Kolnes and Christian Laugesen and Yibing Lu and Bifen Luo and Guoyue Yuan and Robert F Kushner},
  year = {2026},
  doi = {10.1016/s2213-8587(26)00133-6},
  url = {https://pubmed.ncbi.nlm.nih.gov/42575111/},
  note = {Source identifier: 42575111}
}